Structural analyses of choroid after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy

被引:59
|
作者
Izumi, Takahiko [1 ]
Koizumi, Hideki [1 ]
Maruko, Ichiro [1 ]
Takahashi, Yohei [1 ]
Sonoda, Shozo [2 ]
Sakamoto, Taiji [2 ]
Iida, Tomohiro [1 ]
机构
[1] Tokyo Womens Med Univ, Dept Ophthalmol, Tokyo, Japan
[2] Kagoshima Univ, Dept Ophthalmol, Kagoshima, Japan
关键词
OPTICAL COHERENCE TOMOGRAPHY; INDOCYANINE GREEN ANGIOGRAPHY; EYES; BINARIZATION; THICKNESS; IMAGES;
D O I
10.1136/bjophthalmol-2016-308921
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background/aims To investigate the changes in the intrachoroidal structures after half-dose verteporfin photodynamic therapy (PDT) for central serous chorioretinopathy (CSC). Methods Swept-source optical coherence tomography cross-sectional images of 22 eyes of 22 patients with CSC were retrospectively analysed by a manual delineation technique and binarisation method. Results In the 22 eyes, the mean subfoveal choroidal thickness decreased from 412.9 +/- 112.9 mu m at baseline to 340.0 +/- 111.0 mu m at 3 months (p< 0.0001). The mean thickness of the large choroidal vessel layer decreased from 368.7 +/- 112.7 mu m at baseline to 292.2 +/- 118.0 mu m at 3 months (p< 0.0001), but the mean choriocapillarismedium choroidal vessel layer thickness did not change from 44.2 +/- 29.2 mu m at baseline to 47.8 +/- 25.7 mu m at 3 months (p= 0.85). Analyses of the binarised choroidal images showed that a 3 mm subfoveal choroidal area decreased from 1.141 +/- 0.290 mm(2) at baseline to 0.962 +/- 0.320 mm(2) at 3 months after PDT (p= 0.0001). The mean luminal areas decreased from 0.826 +/- 0.246 mm(2) at baseline to 0.665 +/- 0.234 mm(2) at 3 months (p= 0.0001), however, the mean stromal areas did not change from 0.315 +/- 0.066 mm(2) at baseline to 0.297 +/- 0.095 mm(2) at 3 months (p= 0.60). Conclusions Half-dose PDT reduces subfoveal choroidal thickness and alters the intrachoroidal structures in eyes with CSC.
引用
收藏
页码:433 / 437
页数:5
相关论文
共 50 条
  • [1] Macular sensitivity after half-dose verteporfin photodynamic therapy in central serous chorioretinopathy
    Sanguansak, Thuss
    Pitujaturont, Prapapan
    Yospaiboon, Yosanan
    Sinawat, Suthasinee
    Ratanapakorn, Tanapat
    Bhoomibunchoo, Chavakij
    CLINICAL OPHTHALMOLOGY, 2015, 9 : 2257 - 2261
  • [2] Half-Dose Verteporfin Photodynamic Therapy (hdPDT) in the Treatment of Central Serous Chorioretinopathy
    Hoehn, F.
    Kretz, F. T. A.
    Beger, I.
    Koch, F.
    Auffarth, G. U.
    Singh, P.
    Deuchler, S.
    Koss, M. J.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2016, 233 (07) : 860 - 863
  • [3] QUANTIFICATION OF METAMORPHOPSIA IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY AFTER HALF-DOSE VERTEPORFIN PHOTODYNAMIC THERAPY
    Fujita, Kyoko
    Imamura, Yutaka
    Shinoda, Kei
    Matsumoto, Celso Soiti
    Mizutani, Yoshihiro
    Mizota, Atsushi
    Yuzawa, Mitsuko
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2014, 34 (05): : 964 - 970
  • [4] Experiences with chronic central serous chorioretinopathy treated with half-dose photodynamic therapy and verteporfin
    Toeteberg-Harms, M.
    Kurz-Levin, M.
    Fleischhauer, J.
    Windisch, R.
    OPHTHALMOLOGE, 2011, 108 (10): : 947 - 951
  • [5] Half-Dose Verteporfin Combined with Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
    Liu, Chun-Fu
    Chen, Lee-Jen
    Tsai, Shawn H.
    Lai, Chi-Chun
    Chan, Wei-Chun
    Wu, Wei-Chi
    Wang, Nan-Kai
    Chen, Kuan-Jen
    Hwang, Yih-Shiou
    Chen, Yen-Po
    Yeung, Ling
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2014, 30 (05) : 400 - 405
  • [6] Half-dose verteporfin photodynamic therapy for bullous variant of central serous chorioretinopathy: A case report
    Ng W.W.K.
    Wu Z.H.Y.
    Lai T.Y.Y.
    Journal of Medical Case Reports, 5 (1)
  • [7] One-Year Outcomes with Half-Dose Verteporfin Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
    Fujita, Kyoko
    Imamura, Yutaka
    Shinoda, Kei
    Matsumoto, Celso Soiti
    Mizutani, Yoshihiro
    Hashizume, Kouhei
    Mizota, Atsushi
    Yuzawa, Mitsuko
    OPHTHALMOLOGY, 2015, 122 (03) : 555 - 561
  • [8] FLUORESCEIN ANGIOGRAPHY-GUIDED PHOTODYNAMIC THERAPY WITH HALF-DOSE VERTEPORFIN FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
    Koytak, Arif
    Erol, Kazim
    Coskun, Erol
    Asik, Nihal
    Ozturk, Hakan
    Ozerturk, Yusuf
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2010, 30 (10): : 1698 - 1703
  • [9] A combination therapy of half-dose verteporfin photodynamic therapy and intravitreal injection of ranibizumab for chronic central serous chorioretinopathy
    Toklu, Yasin
    Cakmak, Hasan Basri
    Yorgun, Mucella Arikan
    Ergun, Sule Berk
    Simsek, Saban
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2012, 42 (04) : 681 - 688
  • [10] Choroidal Structure after Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
    Alovisi, Camilla
    Piccolino, Felice Cardillo
    Nassisi, Marco
    Eandi, Chiara M.
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) : 1 - 11